Methodology & Disclosures
How we work.
How we evaluate providers, how we make money, what our content is and is not, and what you should know before acting on anything you read here.
Last updated: May 12, 2026
Why this site exists.
Why neutrality matters.
In 2023, a peer-reviewed study published on PMC/NCBI found that only 40% of women who asked their GP for HRT actually received it. Not because they were ineligible. Because their doctors were never trained. Because the 2002 WHI study still casts a shadow it no longer deserves. Because 18-minute appointments do not leave room for nuance.
Another study, this one from the UK Government surveying 100,000 women, found that 30% experienced delays in diagnosis — and 91% felt they had not received enough information about menopause from their provider.
This is not a medical failure in the traditional sense. It is a training gap. A communication gap. A gap between what women need and what the system is designed to deliver.
We built The Menopause Index because we were tired of seeing women navigate this alone — and tired of seeing "comparison" sites that were really just affiliate farms pushing whichever provider paid the highest commission. You deserve better. You deserve a site that tells you the truth about cost, availability, and fit — even when the truth is complicated.
We do not take money for placement. We do not let affiliate relationships influence our rankings. Our rubric is published here, in full, for anyone to read and challenge. If we get something wrong, we correct it. If a provider improves, we update their score. This is how editorial work should work.
Provider ranking methodology
Our provider assessments are based on a published rubric applied consistently across all providers we review. No provider pays for inclusion, higher placement, or a more favorable assessment. If a provider we review also has an affiliate relationship with us, that relationship is disclosed on every page where affiliate links appear.
Our ranking criteria and approximate weighting:
How each criterion is scored
Each criterion is scored on a 5-point scale by our editorial team:
- 5/5 — Exceptional: Best-in-class performance. Sets the standard for the industry.
- 4/5 — Strong: Above average. Meets or exceeds expectations with minor gaps.
- 3/5 — Good: Average performance. Competent but not differentiated.
- 2/5 — Fair: Below average. Notable gaps or limitations.
- 1/5 — Poor: Significant issues. Would not recommend on this criterion alone.
Scores are assigned through independent editorial assessment. We verify claims against provider websites, independent review platforms, and direct user feedback. We do not accept scoring input from providers.
Assessments are described as "Editorial pick," "Strong option," or "Good option" in our editorial judgment. These labels reflect our rubric-based assessment and are not star ratings or guarantees of clinical quality.
Methodology last reviewed: May 2026. Next review: June 2026.
Provider scorecard
May 2026 assessment.
Scores reflect our editorial assessment as of May 2026. We review and update these monthly. See the update log for recent changes.
| Criterion (weight) | Midi Health | Alloy | Winona | Evernow |
|---|---|---|---|---|
| Cost & transparency (30%) |
3.5
|
5.0
|
3.0
|
4.0
|
| Access & availability (25%) |
2.5
|
5.0
|
5.0
|
3.5
|
| Treatment fit (25%) |
4.5
|
4.0
|
3.5
|
4.0
|
| Speed to care (10%) |
3.0
|
5.0
|
4.0
|
5.0
|
| Patient experience (10%) |
4.0
|
4.0
|
3.5
|
4.0
|
| WEIGHTED TOTAL |
3.5
/5
|
4.6
/5
|
3.9
/5
|
4.0
/5
|
How to read this: These are editorial assessments, not clinical quality ratings. A lower score in "Access" does not mean Midi provides worse care — it means they serve fewer states or require video visits, which affects accessibility for some users. Always choose based on your specific needs, not just the highest score.
Scorecard last updated: May 12, 2026. Next update: June 2026.
Editorial Independence Charter
TheMenopauseIndex.org is an independent editorial publication. Our content is produced by an editorial team with no access to affiliate commission data. We do not accept payment for editorial coverage, sponsored articles presented as editorial content, or provider-written content published under our byline.
Correction policy
We take accuracy seriously. Our correction process:
- Acknowledgment: We acknowledge correction requests within 5 business days.
- Investigation: We investigate the claim against our sources within 10 business days.
- Publication: If a correction is warranted, we publish it within 30 days of the original request.
- Notation: Corrections are noted on the relevant page with the date of correction. Significant corrections are also logged in our update log.
Charter last reviewed: May 2026.
Affiliate disclosure
Required FTC disclosure: TheMenopauseIndex.org participates in affiliate programs. When you click certain links on this site and sign up for a service, we may earn a commission at no additional cost to you. This is how we fund our editorial work.
Specifically:
- No provider pays for placement. Rankings and editorial assessments are determined by our published methodology, not by commercial relationships.
- Affiliate links are present on this site. Provider links including "Visit Midi Health," "Visit Alloy," "Visit Winona," and "Visit Evernow" may be affiliate links through programs including Impact, ShareASale, and direct provider programs.
- Affiliate relationships do not influence our assessments. We would recommend a provider we have no affiliate relationship with if our rubric supported it. We disclose when we do and do not have affiliate relationships with providers we review.
- Commission structures vary. We may earn a flat fee, a percentage of a first payment, or a recurring commission depending on the provider program. We do not earn more for ranking a provider higher.
- We also earn from newsletter sponsorships. Sponsors of The Menopause Index Weekly are disclosed in each issue. Sponsors do not influence editorial coverage.
This disclosure applies to all pages on TheMenopauseIndex.org. If you have questions about a specific commercial relationship, contact us at the address below.
Affiliate disclosure last reviewed: May 2026
Editorial policy
TheMenopauseIndex.org is an independent editorial publication. Our content is produced by an editorial team and reviewed for accuracy before publication. We do not accept payment for editorial coverage, sponsored articles presented as editorial content, or provider-written content published under our byline.
What we cover and how:
- Provider comparisons are based on publicly available information from provider websites, independent review sources, and our editorial assessment. We verify pricing against multiple sources and note the date of verification on each page.
- Medical and clinical information is based on published guidance from recognized bodies including the Menopause Society (NAMS), the American College of Obstetricians and Gynecologists (ACOG), and peer-reviewed literature. We cite sources inline. We do not provide personalized medical advice.
- Statistics and data we cite are sourced and linked where possible. Where we cannot independently verify a statistic, we use qualifying language ("based on available data," "according to," "as reported by") and provide the source.
- Provider information is taken from publicly available sources. We do not have access to provider clinical data, patient outcomes, or internal operations. Provider claims about their own services are attributed to the provider.
We aim to update provider comparison pages monthly and note the date of last verification on each page. We cannot guarantee that all information is current at the time you read it. Always verify details directly with providers.
Editorial policy last reviewed: May 2026
Medical disclaimer
This website does not provide medical advice. The content on TheMenopauseIndex.org is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
Specifically:
- The Access Finder Quiz does not diagnose any condition. Quiz results are decision support based on the preferences and information you provide. They are not a clinical assessment and should not be treated as one.
- The Doctor Refusal Navigator provides general information about navigating healthcare access. It does not constitute legal advice, medical advice, or a clinical recommendation for or against any treatment.
- Clinical information on this site reflects published guidance from NAMS, ACOG, and peer-reviewed literature as of the date noted. Clinical guidelines change. Your situation may differ from the general cases these guidelines address.
- Provider information is not a clinical endorsement. Including a provider on this site does not constitute a recommendation that you use that provider. Whether HRT or any other treatment is appropriate for you depends on your individual medical history, which only a qualified clinician can assess.
- Always consult a qualified healthcare professional before starting, stopping, or changing any treatment.
If you are experiencing a medical emergency, call 911 or your local emergency services immediately.
Medical disclaimer last reviewed: May 2026
Sources and citations
Primary sources we cite across this site:
- The Menopause Society (NAMS) — menopause.org. Hormone therapy position statements, provider certification standards, clinical guidance.
- American College of Obstetricians and Gynecologists (ACOG) — acog.org. Practice bulletins on menopause, perimenopause, and HRT.
- Cambridge JMIR Menopause Information Survey (2025) — peer-reviewed survey of 627 menopausal women on information-seeking behavior.
- UK Government Women's Health Survey (2021) — survey of 100,000 women on menopause care experiences.
- PMC/NCBI qualitative study on HRT access (2023) — qualitative research on barriers to HRT prescription.
- Evernow Clinical Study (2021) — internal study of 100,000+ patients. All citations from this study are attributed to Evernow and not independently verified by us.
- Innerbody Research (December 2025) — independent provider pricing verification.
- TelehealthAlly (March 2026) — independent provider pricing and availability verification.
- TheFlowSpace (2026) — independent provider pricing and availability verification.
- NAMS Provider Education data — data on menopause training in medical education.
Provider pricing, state availability, and service details are taken from each provider's public website and verified against independent sources as noted. We note the date of verification on each comparison page. If you find an error in our citations or data, please contact us.
Update log
We believe in transparency about what we change and why. This log records significant updates to our methodology, scores, and content.
Next scheduled review: June 2026. We review provider scores, pricing, and availability monthly. Major methodology changes are announced here and in our newsletter.
Contact and corrections
We take accuracy seriously. If you find an error in our content, a pricing discrepancy, an outdated statistic, or a broken link, please let us know.
For editorial corrections: editorial@themenopauseindex.org
For affiliate or commercial enquiries: partners@themenopauseindex.org
We aim to acknowledge correction requests within 5 business days and to publish corrections prominently on the relevant page.